marijuana stocks

Affinor Growers, Inc. (RSSFF)

Other OTC

0.13 Up 0.00(3.47%) 1:36PM EST
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Nov 30, 2014 Aug 31, 2014 May 31, 2014 Feb 28, 2014
Total Revenue 41   43   –   –  
Cost of Revenue
Gross Profit 41   43   –   –  
Operating Expenses
Research Development
Selling General and Administrative 1,145 1,342 7,187 95
Non Recurring
Others 8 5
Total Operating Expenses
Operating Income or Loss (1,113) (1,304) (7,298) (95)
Income from Continuing Operations
Total Other Income/Expenses Net (12) 21 9 (9)
Earnings Before Interest And Taxes (1,125) (1,283) (7,290) (104)
Interest Expense 0 (1)
Income Before Tax (1,125) (1,283) (7,290) (104)
Income Tax Expense (6) 2
Minority Interest
Net Income From Continuing Ops (1,125) (1,283) (7,283) (105)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (1,125) (1,283) (7,283) (105)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (1,125) (1,283) (7,283) (105)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tilray Brands, Inc. (TLRY) New ‘Half-A-Gummie’ IPA Meets Consumer Demand for Fruity, Easy-Drinking Beers

Crafted for the People: SweetWater’s New ‘Half-A-Gummie’ IPA Meets Consumer Demand for…

$GRCU Gives Corporate Overview and Shareholder Update

Green Cures & Botanical Distribution Inc. provides shareholder update and corporate overview…

$NRTI Supplements Line Now Carried by Palko Services

Inergetics’ OmEssentials® Supplements Line Now Carried by Palko Services Company continues to…

Dragonfly Therapeutics Announces AbbVie (ABBV) Opt-In of TriNKET™ Immunotherapy Drug Candidate

Dragonfly Therapeutics Announces AbbVie Opt-In of TriNKET™ Immunotherapy Drug Candidate Dragonfly Therapeutics…